Home » Topics » Immuno-oncology, BioWorld Science

Immuno-oncology, BioWorld Science
RSS

Ribi seeks approval for melanoma vaccine in Canada

Sep. 9, 1997

Vical's Allovectin-7 enters phase II for head and neck cancer

Sep. 8, 1997

TNT nears clinical trials

Sep. 2, 1997

FDA requests additional manufacturing data before approval of Rituxan

Sep. 1, 1997

Dovetail issued patent for Betathine

Aug. 28, 1997

Malignant melanoma indication approved for Intron A in U.K.

Aug. 27, 1997

Theratope vaccine advances to phase III trials

Aug. 21, 1997

Novopharm Biotech antibodies poised to enter phase I

Aug. 19, 1997

NeoRx and Janssen enter agreement for Avicidin

Aug. 14, 1997

ImClone Systems earns manufacturing milestone from Merck KGaA

Aug. 4, 1997

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Jan 9, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for Jan. 9, 2026.
ADCs’ breakout 2025 and their still-unfinished potential
BioWorld Science
Over the course of the year, and continuing into the latest scientific meetings, an extraordinary breadth of new antibody-drug conjugate (ADC) designs was...
Development and characterization of anti-CD19 in vivo CAR T therapy
BioWorld Science
Shenzhen Grit Biotechnology Co. Ltd. and Shanghai Vitalgen Biopharma Co. Ltd. recently presented their work to develop and evaluate a novel anti-CD19 in vivo CAR...
Preclinical results of anti-ADAMTS13 antibody in acquired von Willebrand syndrome
BioWorld Science
The acquired von Willebrand syndrome (AVWS) is a rare bleeding disorder with laboratory findings similar to those of inherited von Willebrand disease. Researchers...